A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults

References

• Amuzie CJ, Pestka JJ. (2010). Suppression of insulin like growth factor acid labile subunit (IGFALS) expression – a novel mechanism for deoxynivalenol induced growth retardation. Toxicol Sci 113:412–21.
   PubMed Web of Science ®Google Scholar
• Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. (2005). Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192–200.
   PubMed Web of Science ®Google Scholar
• Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. (1989). Outbreak of trichothecenes mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet 1:35–7.
   PubMed Web of Science ®Google Scholar
• Canady R, Coker R, Egan S, Krska R, Kuiper-Goodman T, Olsen M, Pestka J, Resnik S, Schlatter J. (2001). Deoxynivalenol. In: Safety Evaluation of Certain Mycotoxins in Food. Geneva: World Health Organization.
   Google Scholar
• CAST. (2003). Potential economic costs of mycotoxins in the United States. In: Mycotoxins: Risks in Plant, Animal, and Human Systems. Task Force Report no. 139. Ames, IA: Council for Agricultural Science and Technology. p.136–42.
   Google Scholar
• Department of Health. (1991). Dietary reference values for food energy and nutrients for the United Kingdom. Report of the panel on dietary reference values of the committee on medical aspects of food policy. London: Department of Health.
   Google Scholar
• Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. (2001). Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA 98:14601–6.
   PubMed Web of Science ®Google Scholar
• EU. (2006). Laying down the methods of sampling and analysis for the official control of the levels of mycotoxins in foodstuffs. Commission regulation (EC) no. 401/2006. Available at: http://www.health.gov.mt/fsc/fsc_EU.eg_files/RegEC401_2006e.pdf (last accessed 18 May 2010).
   Google Scholar
• Gilbert J, Brereton P, MacDonald S. (2001). Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Add Contam 18:1088–93.
   PubMed Web of Science ®Google Scholar
• Gong Y, Torres-Sanchez L, Lopez-Carrillo L, Peng JH, Sutcliffe AE, White KLM, Turner PC, Humpf H, Wild CP. (2008). Detection of fumonisin B1 in Mexican urine samples using liquid chromatography–mass spectrometry – a possible biomarker of dietary fumonisin exposure. Cancer Epidemiol Biomarkers Prev 17:688–94.
   PubMed Web of Science ®Google Scholar
• Gong YY, Cardwell K, Hounsa A, Egal S, Turner PC, Hall AJ, Wild CP. (2002). Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo, West Africa: cross sectional study. BMJ 325:20–1.
   PubMed Web of Science ®Google Scholar
• Goyarts T, Danicke S. (2006). Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig. Toxicol Lett 163:171–82.
   PubMed Web of Science ®Google Scholar
• Gray JS, Pestka JJ. (2007). Transcriptional regulation of deoxynivalenol-induced IL-8 expression in human monocytes. Toxicol Sci 99:502–11.
   PubMed Web of Science ®Google Scholar
• Groopman JD, Jackson PE, Turner PC, Wild CP, Kensler TW. (2002). Validation of exposure and risk biomarkers: aflatoxin as a case study. In: Wilson SH, Suk WA, eds. Biomarkers of Environmentally Associated Disease. Boca Raton, FL: CRC Press. p. 307–18.
   Google Scholar
• Groopman JD, Wild CP, Hasler J, Junshi C, Wogan GN, Kensler TW. (1993). Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Environ Health Perspect 99:107–13.
   PubMed Web of Science ®Google Scholar
• Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT. (1992). McCance and Widdowson’s The Composition of Foods, 5th edn. London: The Royal Society of Chemistry and the Ministry of Agriculture Fisheries and Food.
   Google Scholar
• Hopton RP, Turner E, Burley VJ, Turner PC, Fisher J. (2010). Urine metabolite analysis as a function of deoxynivalenol exposure: an NMR-based metabolomics investigation. Food Add Contam 27:255–61.
   Web of Science ®Google Scholar
• International Agency for Research on cancer (IARC). (2002). Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. Report no. 82. Lyon: World Health Organization, IARC. p. 1–556.
   Google Scholar
• Jiang Y, Jolly PE, Ellis WO, Wang JS, Phillips TD, Williams JH. (2005). Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians. Int Immunol 17:807–14.
   PubMed Web of Science ®Google Scholar
• Joint Expert Committee on Food Additives. (2001). Deoxynivalenol. Available at: http://www.inchem.org/documents/jecfa/jecmono/v47je05.htm (last accessed 15 June 2007).
   Google Scholar
• Kensler TW, He X, Otieno M, Egner PA, Jacobson LP, Chen B, Wang J, Zhu W, Zhang B, Wang J, Wu Y, Zhang Q, Qian G, Kuang S, Fang X, Li Y, Yu L, Prochaska HJ, Davidson NE, Gordon GB, Gorman MB, Zarba A, Enger C, Munoz A, Helzlsouer KJ, Groopman JD. (1998). Oltipraz chemoprevention trial in Qidong, People’s Republic of China: modulation of serum aflatoxins-albumin adduct biomarkers. Cancer Epidemiol Biomarkers Prev 7:127–34.
   PubMed Web of Science ®Google Scholar
• Luo X. (1994). Food poisoning caused by Fusarium toxins. In: Proceedings of the Second Asian Conference on Food Safety. p. 129–36.
   Google Scholar
• Meky FA, Hardie LJ, Evans SW, Wild CP. (2001). Deoxynivalenol-induced immunomodulation of human lymphocyte proliferation and cytokine production. Food Chem Toxicol 39:827–36.
   PubMed Web of Science ®Google Scholar
• Meky FA, Turner PC, Ashcroft AE, Miller JD, Qiao YL, Roth MJ, Wild CP. (2003). Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol 41:265–73.
   PubMed Web of Science ®Google Scholar
• Miller JD. (1995). Fungi and mycotoxins in grain: implications for stored product research. J Stored Prod Res 31:1–16.
   Web of Science ®Google Scholar
• Nikiema PN, Worrilow L, Traore AS, Wild CP, Turner PC. (2008). Fumonisin exposure and the Shinganine/Sphingosine ratio in urine, serum and buccal cells in adults from Burkina Faso, West Africa. World Mycotoxin J 1:483–91.
   Web of Science ®Google Scholar
• Pestka JJ, Zhou HR, Moon Y, Chung YJ. (2004). Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol Lett 153:61–73.
   PubMed Web of Science ®Google Scholar
• Pestka, JJ, Smolinski AT. (2005). Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Health B Crit Rev 8:39–69.
   PubMed Web of Science ®Google Scholar
• Prelusky DB, Hartin KE, Trenholm HL, Miller JD. (1998). Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine. Fundam Appl Toxicol 10:276–86.
   Google Scholar
• Prelusky DB. (1997). Effect of intraperitoneal infusion of deoxynivalenol on feed consumption and weight gain in the pig. Nat Toxins 5:121–5.
   PubMedGoogle Scholar
• Rotter BA, Prelusky DB, Pestka JJ. (1996). Toxicology of deoxynivalenol (vomitoxin). J Toxicol Environ Health 48:1–34.
   PubMed Web of Science ®Google Scholar
• SCF (2002). Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol: 2002SCF/CS/CNTM/MYC/27 Final. Available at: http://ec.europa.eu/geninfo/query/resultaction.jsp?userinput=SCF%202002%20deoxynivalenol> (accessed 18th June 2010).
   Google Scholar
• SCOOP. (2003). Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states. scoop Task 3.2.10 Final report. Available at: <http://ec.europa.eu/food/food/chemicalsafety/contaminants/fusarium_en.print.htm> (accessed 18th June 2010).
   Google Scholar
• Shephard GS, Van der Westhuizen L, Sewram V. (2007). Biomarkers of exposure to fumonisin mycotoxins: a review. Food Add Contam 24:1196–201.
   PubMed Web of Science ®Google Scholar
• Sugiyama KI, Muroi M, Tanamoto KI, Nishijima, M, Sugita-Konishi Y. (2010). Deoxynivalenol and nivalenol inhibit lipopolysaccharide-induced nitric oxide production by mouse macrophage cells. Toxicol Lett 192:150–4
   PubMedGoogle Scholar
• Turner PC, Burley VJ, Rothwell JA, White KLM, Cade JE, Wild CP. (2008b). Deoxynivalenol: rationale for development and application of a urinary biomarker. Food Add Contam 25:864–71.
   Web of Science ®Google Scholar
• Turner PC, Burley VJ, Rothwell JA, White KLM, Cade JE, Wild CP. (2008a). Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. J Exposure Sci Env Epidemiol 18:392–9.
   PubMed Web of Science ®Google Scholar
• Turner PC, Collinson AC, Cheung YB, Gong Y, Hall AJ, Prentice AM, Wild CP. (2007). Aflatoxin exposure in utero causes growth faltering in Gambian infants. Int J Epidemiol 36:1119–25.
   PubMed Web of Science ®Google Scholar
• Turner PC, Hopton RP, Lecluse Y, White KLM, Fisher J, Lebailly P. (2010). Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. J Agri Food Chem 58:5206–12.
   PubMed Web of Science ®Google Scholar
• Turner PC, Moore SE, Hall AJ, Prentice AM, Wild CP. (2003). Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ Health Persp 111:217–20.
   PubMed Web of Science ®Google Scholar
• Turner PC, Nikiema P, Wild CP. (1999). Fumonisin contamination of food: progress in development of biomarkers to better assess human health. Mut Res 443:81–93.
   PubMed Web of Science ®Google Scholar
• Turner PC, Rothwell JA, White KLM, Cade JE, Wild CP. (2008c). Urinary deoxynivalenol is correlated with cereal intake in individuals from the United Kingdom Environ Health Persp 116:21–5.
   PubMed Web of Science ®Google Scholar
• Turner PC, Sylla A, Gong YY, Diallo MS, Sutcliffe AE, Hall AJ, Wild CP. (2005). Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in West Africa: a community-based intervention study. Lancet 365:1950–6.
   PubMed Web of Science ®Google Scholar
• Turner PC, Taylor F, White KLM, Cade JE, Wild CP. (2009). A comparison of 24 hour urinary deoxynivalenol with recent versus usual cereal consumption for UK adults. Br J Nutr 102:1276–9.
   PubMed Web of Science ®Google Scholar
• Van De Walle J, Romier B, Larondelle Y, Schneider YJ. (2008). Influence of deoxynivalenol on NF-kappaB activation and IL-8 secretion in human intestinal Caco-2 cells. Toxicol Lett 177:205–14.
   PubMed Web of Science ®Google Scholar
• Varley H. (1967). Practical Clinical Biochemistry. London and New York: William Weimann Medical Books and Interscience Books, Inc.
   Google Scholar
• Voss KA. (2009) A new perspective on deoxynivalenol and growth suppression. Toxicol Sci 113:281–3.
   PubMedGoogle Scholar
• Wache YJ, Hbabi-Haddioui L, Guzylack-Pirou Belkhelfa, H, Roques C, Oswald IP. (2009). The mycotoxin deoxynivalenol inhibits the cell surface expression of activation markers in human macrophages. Toxicology 262:239–44.
   PubMed Web of Science ®Google Scholar
• Wang P, Afriyie-Gyawu E, Tang Y, Johnson NM, Xu L, Tang L, Huebner HJ, Ankrah NA, Ofori-Adjei D, Ellis W, Jolly PE, Williams JH, Wang JS, Phillips TD. (2008). NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in in biomarkers of aflatoxins exposure in blood and urine. Food Add Contam Part A Chem Anal Control Expo Risk Assess 25:622–34.
   PubMed Web of Science ®Google Scholar